Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.40 billion. The enterprise value is $3.13 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.13 million shares outstanding. The number of shares has increased by 3.91% in one year.
| Current Share Class | 143.13M |
| Shares Outstanding | 143.13M |
| Shares Change (YoY) | +3.91% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 20.47% |
| Float | 23.92M |
Valuation Ratios
The trailing PE ratio is 10.28 and the forward PE ratio is 8.70. Ardent Health's PEG ratio is 2.25.
| PE Ratio | 10.28 |
| Forward PE | 8.70 |
| PS Ratio | 0.23 |
| Forward PS | 0.21 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 3.93 |
| P/FCF Ratio | 6.65 |
| P/OCF Ratio | 3.33 |
| PEG Ratio | 2.25 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.23, with an EV/FCF ratio of 14.34.
| EV / Earnings | 23.28 |
| EV / Sales | 0.49 |
| EV / EBITDA | 6.23 |
| EV / EBIT | 9.21 |
| EV / FCF | 14.34 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 1.32.
| Current Ratio | 2.12 |
| Quick Ratio | 1.36 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 2.99 |
| Debt / FCF | 10.49 |
| Interest Coverage | 6.38 |
Financial Efficiency
Return on equity (ROE) is 13.94% and return on invested capital (ROIC) is 8.12%.
| Return on Equity (ROE) | 13.94% |
| Return on Assets (ROA) | 4.17% |
| Return on Invested Capital (ROIC) | 8.12% |
| Return on Capital Employed (ROCE) | 7.89% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $255,118 |
| Profits Per Employee | $5,328 |
| Employee Count | 25,200 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 22.16 |
Taxes
In the past 12 months, Ardent Health has paid $57.09 million in taxes.
| Income Tax | 57.09M |
| Effective Tax Rate | 19.91% |
Stock Price Statistics
The stock price has decreased by -25.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.89% |
| 50-Day Moving Average | 9.32 |
| 200-Day Moving Average | 10.72 |
| Relative Strength Index (RSI) | 52.90 |
| Average Volume (20 Days) | 353,201 |
Short Selling Information
The latest short interest is 2.93 million, so 2.05% of the outstanding shares have been sold short.
| Short Interest | 2.93M |
| Short Previous Month | 2.78M |
| Short % of Shares Out | 2.05% |
| Short % of Float | 12.27% |
| Short Ratio (days to cover) | 8.57 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.43 billion and earned $134.28 million in profits. Earnings per share was $0.95.
| Revenue | 6.43B |
| Gross Profit | 3.77B |
| Operating Income | 339.41M |
| Pretax Income | 286.75M |
| Net Income | 134.28M |
| EBITDA | 501.89M |
| EBIT | 339.41M |
| Earnings Per Share (EPS) | $0.95 |
Full Income StatementBalance Sheet
The company has $609.69 million in cash and $2.29 billion in debt, with a net cash position of -$1.68 billion or -$11.71 per share.
| Cash & Cash Equivalents | 609.69M |
| Total Debt | 2.29B |
| Net Cash | -1.68B |
| Net Cash Per Share | -$11.71 |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 9.34 |
| Working Capital | 1.07B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $435.08 million and capital expenditures -$217.08 million, giving a free cash flow of $217.99 million.
| Operating Cash Flow | 435.08M |
| Capital Expenditures | -217.08M |
| Depreciation & Amortization | 162.49M |
| Net Borrowing | -3.35M |
| Free Cash Flow | 217.99M |
| FCF Per Share | $1.52 |
Full Cash Flow StatementMargins
Gross margin is 58.60%, with operating and profit margins of 5.28% and 2.09%.
| Gross Margin | 58.60% |
| Operating Margin | 5.28% |
| Pretax Margin | 4.46% |
| Profit Margin | 2.09% |
| EBITDA Margin | 7.81% |
| EBIT Margin | 5.28% |
| FCF Margin | 3.39% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.91% |
| Shareholder Yield | -3.91% |
| Earnings Yield | 9.26% |
| FCF Yield | 15.03% |
Analyst Forecast
The average price target for Ardent Health is $13.20, which is 35.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.20 |
| Price Target Difference | 35.11% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
